Today, the American Diabetes Association® (ADA) announced a collaboration with OpenEvidence, an AI platform delivering evidence-grounded answers to more than 500,000 U.S. health care professionals, to offer improved access to the ADA’s Standards of Care in Diabetes (Standards of Care).
The ADA’s Standards of Care is the gold standard for clinical practice, distilling the latest scientific research and clinical trials into actionable guidance for:
- Diagnosing and treating diabetes in both youth and adults
- Methods to prevent or delay type 2 diabetes and its associated comorbidities like obesity
- Care recommendations to enhance health outcomes
The new collaboration will allow clinicians to easily access and utilize current guidelines relating to specific needs, increasing the ability to keep pace with new research in an era of rising demands on health care professional time. Intelligent search through OpenEvidence will enable clinicians to input questions and receive responses based on the ADA’s guidelines and resources, all within the context of broader medical literature.
“Nonprofit health organizations like the ADA play a critical role in synthesizing and generating the evidence that drives clinical practice. At OpenEvidence, we are deeply committed to making sure that these organizations are an integral part of the next generation of health care technology. This collaboration is part of our effort to keep the ADA’s expertise in improving standards of care central to the new ways physicians are seamlessly applying evidence at the point of care.
We are also delighted to collaborate with the ADA in enhancing their Standards of Care, providing feedback through insight into how guidelines are applied in real-world scenarios and identifying critical areas of clinical uncertainty that new guidelines could address. This marks an exciting step as OpenEvidence moves from being the most trusted source for answering medical questions to becoming an active partner in supporting the creation of evidence that shapes the future of medicine,” said Travis Zack, MD, PhD, chief medical officer at OpenEvidence.
The collaboration will also enable elevation of frontline needs, identifying the information practitioners seek most and raising topics for the ADA’s guideline committee to consider for review. The additional lines of communication will offer insight into aligning the comprehensive, evidence-based recommendations in the Standards of Care with real-world use.
“The purpose of the Standards of Care is to enable health care professionals to provide the best possible care for those living with diabetes. Through this collaboration, the ADA looks forward to tapping new and evolving ways to support clinicians in offering high quality diabetes care,” said Rita Rastogi Kalyani, MD, MHS, ADA’s chief scientific and medical officer.
###
About OpenEvidence
OpenEvidence is a clinician-first artificial-intelligence platform that transforms peer-reviewed literature and professional guidelines into concise, evidence-anchored answers at the point of care. Built by physicians and data scientists, OpenEvidence delivers evidence based medical answers with accurate attributions sourced only from trusted medical sources to more than 500,000 health-care professionals across the United States.
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
